Transforming Growth Factorβ1 Overexpression Is Associated with Insulin Resistance and Rapidly Progressive Kidney Fibrosis under Diabetic Conditions

• Published in: International journal of molecular sciences Vol. 23; no. 22; p. 14265
• Main Authors: D'Alessandro, Valeria Fridman, Takeshita, Atsuro, Yasuma, Taro, Toda, Masaaki, D'Alessandro-Gabazza, Corina N, Okano, Yuko, Tharavecharak, Suphachai, Inoue, Chisa, Nishihama, Kota, Fujimoto, Hajime, Kobayashi, Tetsu, Yano, Yutaka, Gabazza, Esteban C
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 17-11-2022; MDPI
• Subjects: Animals; Blood glucose; Cell lines; Communication; Creatinine; Diabetes; Diabetes mellitus; Diabetes Mellitus - pathology; Diabetic Nephropathies - drug therapy; Diabetic Nephropathies - genetics; Diabetic nephropathy; End-stage renal disease; Fibroblasts; Fibrosis; Glucose; Glucose - metabolism; glucose intolerance; Glucose tolerance; Homeostasis; Humans; Insulin; Insulin Resistance; Kidney - metabolism; Kidney diseases; Kidneys; Mice; Mice, Transgenic; Muscles; Nephropathy; Obesity; Pathogenesis; Plasma; Public health; Renal function; Rodents; Skeletal muscle; Streptozocin; transforming growth factorβ; Transgenic mice; glucose intolerance; diabetes mellitus; insulin resistance; transforming growth factorβ
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms232214265

Diabetes mellitus is a global health problem. Diabetic nephropathy is a common complication of diabetes mellitus and the leading cause of end-stage renal disease. The clinical course, response to therapy, and prognosis of nephropathy are worse in diabetic than in non-diabetic patients. The role of transforming growth factorβ1 in kidney fibrosis is undebatable. This study assessed whether the overexpression of transforming growth factorβ1 is associated with insulin resistance and the rapid progression of transforming growth factorβ1-mediated nephropathy under diabetic conditions. Diabetes mellitus was induced with streptozotocin in wild-type mice and transgenic mice with the kidney-specific overexpression of human transforming growth factorβ1. Mice treated with saline were the controls. Glucose tolerance and kidney fibrosis were evaluated. The blood glucose levels, the values of the homeostasis model assessment for insulin resistance, and the area of kidney fibrosis were significantly increased, and the renal function was significantly impaired in the diabetic transforming growth factorβ1 transgenic mice compared to the non-diabetic transgenic mice, diabetic wild-type mice, and non-diabetic mice. Transforming growth factorβ1 impaired the regulatory effect of insulin on glucose in the hepatocyte and skeletal muscle cell lines. This study shows that transforming growth factorβ1 overexpression is associated with insulin resistance and rapidly progressive kidney fibrosis under diabetic conditions in mice.